China BlueChemical Ltd. (CHINA BLUECHEM) has released its Monthly Return for the period ended 30 September 2026, confirming that both authorised and issued share capital remained unchanged during the month.

Authorised / Registered Capital • Ordinary H shares: 1.80 billion shares at RMB 1 par value, representing RMB 1.80 billion in authorised capital. • Domestic ordinary shares: 2.81 billion shares at RMB 1 par value, representing RMB 2.81 billion in authorised capital. • Total authorised share capital stood at RMB 4.61 billion, identical to the prior month.

Issued Shares and Treasury Position • Issued H shares: 1.80 billion; treasury shares: nil. • Issued domestic shares: 2.81 billion; treasury shares: nil. • No share issuance, cancellation, repurchase or conversion activities were recorded in September, leaving total issued shares at 4.61 billion.

Public Float Compliance CHINA BLUECHEM confirmed compliance with Main Board Rule 13.32D(1), maintaining a minimum public float of at least 25 % for its H-share class as of 30 September 2026.

Capital Instruments The company reported no outstanding share options, warrants, convertible securities or other equity-linked instruments during the reporting period.

Administrative Confirmation All statutory and regulatory requirements related to the company’s share capital were affirmed as satisfied, according to the submission signed by Company Secretary Kuang Xiaobing on 5 October 2026.

Overall, the September 2026 filing indicates a stable capital structure with full adherence to Hong Kong Stock Exchange listing obligations and no equity dilution activities during the month.